Geron Corp (GERN)

[rx7171]

Chris:

The quote from the article is
>>Geron chief executive Tom Okarma declared that his Menlo Park, Calif., company planned to begin clinical trials using embryonic stem cells to treat acute spinal cord injury within the year. Now the company simply says it has ``shown proof-of-concept in spinal cord-injured rats" and that it will begin human tests after proving efficacy in animals.<<

Notice the reporter is quoting Tom's ``shown proof-of-concept in spinal cord-injured rats" but is not directly quoting him when she adds >>that it will begin human tests after proving efficacy in animals.<<

There is nothing new in what she says. But it is spun in a way that makes Tom appear to be leaving the date of starting human tests possibly far in the future.

We all know Geron has a history of missing deadlines. Considering all the obstacles, many political, thrown in its path it's making excellent progress.

You and I and a lot of others have been very very patient because we believe the company is heading in the right direction but really wish we'd get some solid results.

Bob